Form 4: Mural Oncology Director Susan Altschuller Acquires Shares
SEC Form 4 Filing
Director Susan Altschuller purchased 10,000 ordinary shares of Mural Oncology plc at a weighted average price of $3.2071 on August 14, 2024.
Summary
- On August 14, 2024, Susan Altschuller, a director of Mural Oncology plc, acquired 10,000 ordinary shares of the company.
- The shares were purchased at a weighted average price of $3.2071, with individual prices ranging from $3.17 to $3.25.
- Following the transaction, Ms. Altschuller beneficially owns 10,000 ordinary shares.
Sentiment
Score: 5
Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is neither particularly positive nor negative as it's a routine disclosure.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- The purchase of shares by a director could be viewed positively by shareholders as it may indicate confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of transaction: Susan Altschuller purchased 10,000 ordinary shares. |
| 08/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.